Jon P. Gockerman

6.7k total citations
128 papers, 4.4k citations indexed

About

Jon P. Gockerman is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Jon P. Gockerman has authored 128 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 45 papers in Pathology and Forensic Medicine and 41 papers in Genetics. Recurrent topics in Jon P. Gockerman's work include Lymphoma Diagnosis and Treatment (37 papers), Chronic Lymphocytic Leukemia Research (29 papers) and Lung Cancer Treatments and Mutations (20 papers). Jon P. Gockerman is often cited by papers focused on Lymphoma Diagnosis and Treatment (37 papers), Chronic Lymphocytic Leukemia Research (29 papers) and Lung Cancer Treatments and Mutations (20 papers). Jon P. Gockerman collaborates with scholars based in United States, United Kingdom and India. Jon P. Gockerman's co-authors include Joseph O. Moore, Robert C. Bast, Gregg A. Olsen, W. P. Peters, R B Jones, E.J. Shpall, Jeffrey L. Johnson, John M. Allen, M Ruggiero and A. Thomas Look and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Jon P. Gockerman

126 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jon P. Gockerman United States	36	1.5k	1.1k	908	879	875	128	4.4k
Lothar Bergmann Germany	39	1.4k 0.9×	1.4k 1.2×	662 0.7×	798 0.9×	1.0k 1.2×	182	4.8k
David D. Hurd United States	35	1.6k 1.0×	2.4k 2.1×	808 0.9×	990 1.1×	494 0.6×	159	4.8k
K. Höffken Germany	36	2.6k 1.7×	855 0.8×	748 0.8×	967 1.1×	788 0.9×	186	5.4k
Marc Maynadié France	36	1.7k 1.1×	1.4k 1.3×	1.2k 1.4×	1.8k 2.1×	802 0.9×	132	5.5k
Joseph M. Tuscano United States	34	1.3k 0.9×	618 0.5×	777 0.9×	1.4k 1.6×	932 1.1×	150	4.3k
Pia Raanani Israel	35	878 0.6×	1.6k 1.4×	920 1.0×	669 0.8×	673 0.8×	305	4.2k
Ulrich Jäger Austria	45	1.7k 1.1×	2.4k 2.1×	1.2k 1.3×	1.0k 1.2×	1.2k 1.3×	172	5.7k
Michael L. Grossbard United States	37	2.3k 1.5×	482 0.4×	859 0.9×	1.8k 2.1×	828 0.9×	120	4.7k
Roy B. Jones United States	43	2.5k 1.6×	3.4k 3.0×	1.2k 1.3×	735 0.8×	791 0.9×	176	6.6k
Peter F. Coccia United States	44	1.5k 1.0×	1.7k 1.5×	956 1.1×	1.1k 1.2×	657 0.8×	108	5.7k

Countries citing papers authored by Jon P. Gockerman

Since Specialization

Citations

This map shows the geographic impact of Jon P. Gockerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon P. Gockerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon P. Gockerman more than expected).

Fields of papers citing papers by Jon P. Gockerman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon P. Gockerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon P. Gockerman. The network helps show where Jon P. Gockerman may publish in the future.

Co-authorship network of co-authors of Jon P. Gockerman

This figure shows the co-authorship network connecting the top 25 collaborators of Jon P. Gockerman. A scholar is included among the top collaborators of Jon P. Gockerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon P. Gockerman. Jon P. Gockerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Horn, Leora, Jeffrey R. Infante, Karen L. Reckamp, et al.. (2018). Ensartinib (X-396) in ALK-Positive Non–Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study. Clinical Cancer Research. 24(12). 2771–2779. 131 indexed citations

Wakelee, Heather A., Jeffrey R. Infante, George R. Blumenschein, et al.. (2016). P1.44 (also presented as PD2.02): Phase I/II Trial of X-396, A Novel ALK Inhibitor, in Patients With ALK+ NSCLC. Journal of Thoracic Oncology. 11(10). S209–S210. 3 indexed citations

Horn, Leora, Heather A. Wakelee, Karen L. Reckamp, et al.. (2016). MINI01.02: Response and Plasma Genotyping from Phase I/II Trial of Ensartinib (X-396) in Patients (pts) with ALK+ NSCLC. Journal of Thoracic Oncology. 11(11). S256–S257. 7 indexed citations

Brander, Danielle M., David A. Rizzieri, Jon P. Gockerman, et al.. (2013). Phase II open label study of the oral vascular endothelial growth factor-receptor inhibitor PTK787/ZK222584 (vatalanib) in adult patients with refractory or relapsed diffuse large B-cell lymphoma. Leukemia & lymphoma. 54(12). 2627–2630. 5 indexed citations

Uronis, Hope E., Johanna C. Bendell, Gerard C. Blobe, et al.. (2013). A phase I study ofABT‐510 plus bevacizumab in advanced solid tumors. Cancer Medicine. 2(3). 316–324. 21 indexed citations

Ettinger, David S., Mark Agulnik, Justin Cates, et al.. (2011). Occult Primary. Journal of the National Comprehensive Cancer Network. 9(12). 1358–1395. 35 indexed citations

Mowery, Yvonne M., J. Brice Weinberg, Margaret Kennedy, et al.. (2010). LMP-420: a novel purine nucleoside analog with potent cytotoxic effects for CLL cells and minimal toxicity for normal hematopoietic cells. Leukemia. 24(9). 1580–1587. 5 indexed citations

Friedman, Daphne R., J. Brice Weinberg, William T. Barry, et al.. (2009). A Genomic Approach to Improve Prognosis and Predict Therapeutic Response in Chronic Lymphocytic Leukemia. Clinical Cancer Research. 15(22). 6947–6955. 28 indexed citations

Smith, Sonali M., Bruce D. Cheson, George P. Canellos, et al.. (2009). Recombinant interferon-α2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691. Leukemia & lymphoma. 50(10). 1606–1617. 5 indexed citations

10.

Peterson, B. A., Jeffrey L. Johnson, Margaret A. Shipp, et al.. (2007). High dose CHOP: A phase II study of initial treatment in aggressive non-Hodgkin lymphoma. Cancer and Leukemia Group B 9351. Leukemia & lymphoma. 48(5). 870–880. 2 indexed citations

11.

DeAngelo, Daniel J., Daohai Yu, Jeffrey L. Johnson, et al.. (2007). Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801. Blood. 109(12). 5136–5142. 199 indexed citations

12.

Arcasoy, Murat O. & Jon P. Gockerman. (2007). Aplastic anaemia as an autoimmune complication of thymoma. British Journal of Haematology. 137(4). 272–272. 3 indexed citations

13.

Creel, Patricia, William P. Petros, Jon P. Gockerman, et al.. (2006). Phase I/II study of docetaxel and atrasentan in men with metastatic hormone-refractory prostate cancer (HRPC). Journal of Clinical Oncology. 24(18_suppl). 14504–14504. 7 indexed citations

14.

Gasparetto, Cristina, George P. Keogh, Jon P. Gockerman, et al.. (2005). A Prospective Study of Bortezomib in Combination with Melphalan and Prednisone for Patients with Previously Untreated Multiple Myeloma.. Blood. 106(11). 5181–5181. 1 indexed citations

15.

Safford, Shawn D., Robert E. Coleman, Jon P. Gockerman, et al.. (2003). Iodine -131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma. Surgery. 134(6). 956–962. 102 indexed citations

16.

Brown, M., et al.. (1995). Primary central nervous system lymphoma with systemic metastasis: Case report and review. Journal of Neuro-Oncology. 23(3). 207–221. 8 indexed citations

17.

Shami, Paul J., Joseph O. Moore, Jon P. Gockerman, et al.. (1995). Nitric oxide modulation of the growth and differentiation of freshly isolated acute non-lymphocytic leukemia cells. Leukemia Research. 19(8). 527–533. 52 indexed citations

18.

Ortel, Thomas L., Jon P. Gockerman, Robert M. Califf, et al.. (1992). Parenteral Anticoagulation with the Heparinoid Lomoparan (Org 10172) in Patients with Heparin Induced Thrombocytopenia and Thrombosis. Thrombosis and Haemostasis. 67(3). 292–296. 42 indexed citations

19.

Gockerman, Jon P., et al.. (1975). Detection of platelet isoantibodies by (3H)serotonin platelet release and its clinical application to the problem of platelet matching.. Journal of Clinical Investigation. 55(1). 75–83. 34 indexed citations

20.

Joseph, K. C. & Jon P. Gockerman. (1975). Accumulation of glycolipids containing N-acetylglucosamine in erythrocyte stroma of patients with congenital dyserythropoietic anemia type II (HEMPAS). Biochemical and Biophysical Research Communications. 65(1). 146–152. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact